Clinical Trials Insight: 700026203
Latest Information Update: 20 Aug 2007
At a glance
- Drugs LE SN38 (Primary)
- Indications Triple negative breast cancer
- Focus Therapeutic Use
- Sponsors NeoPharm Inc
Most Recent Events
- 20 Aug 2007 New trial record.
Latest Information Update: 20 Aug 2007